Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefano Landi

Showing results (101-110 of 212) with videos related to

Pageof 22
Sort By:
Age (Dordrecht, Netherlands)|May 12, 2012
MAP3K7 and GSTZ1 are associated with human longevity: a two-stage case-control study using a multilocus genotypingFausta Di Cianni, Daniele Campa, Federica Tallaro, et al.
Carcinogenesis|November 18, 2009
An insertion/deletion polymorphism at miRNA-122-binding site in the interleukin-1alpha 3' untranslated region confers risk for hepatocellular carcinomaYuzhen Gao, Yan He, Jun Ding, et al.
Carcinogenesis|December 15, 2011
The role of microRNA-binding site polymorphisms in DNA repair genes as risk factors for bladder cancer and breast cancer and their impact on radiotherapy outcomesMark T W Teo, Debora Landi, Claire F Taylor, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 5, 2016
A Comprehensive Meta-analysis of Case-Control Association Studies to Evaluate Polymorphisms Associated with the Risk of Differentiated Thyroid CarcinomaGisella Figlioli, Rossella Elisei, Cristina Romei, et al.
Plos One|January 28, 2014
MSLN gene silencing has an anti-malignant effect on cell lines overexpressing mesothelin deriving from malignant pleural mesotheliomaOmbretta Melaiu, Justin Stebbing, Ylenia Lombardo, et al.
Cancers|May 28, 2022
A Drug Screening Revealed Novel Potential Agents against Malignant Pleural MesotheliomaIrene Dell'Anno, Alessandra Melani, Sarah A Martin, et al.
Human Mutation|February 4, 2010
DeltaN133p53 expression levels in relation to haplotypes of the TP53 internal promoter regionIlaria Bellini, Letizia Pitto, Maria G Marini, et al.
BMC Cancer|March 18, 2016
Runs of homozygosity and inbreeding in thyroid cancerHauke Thomsen, Bowang Chen, Gisella Figlioli, et al.
Thyroid : Official Journal of the American Thyroid Association|April 2, 2020
Polymorphisms Within the <i>RET</i> Proto-Oncogene and Risk of Sporadic Medullary Thyroid CarcinomaFederica Gemignani, Cristina Romei, Raffaele Ciampi, et al.
International Journal of Hygiene and Environmental Health|October 8, 2008
Pooled analysis of NAT2 genotypes as risk factors for asbestos-related malignant mesotheliomaMarta Betti, Monica Neri, Daniela Ferrante, et al.
Pageof 22

Showing results (101-110 of 212) with videos related to

Sort By:
Pageof 22
Age (Dordrecht, Netherlands)|May 12, 2012
MAP3K7 and GSTZ1 are associated with human longevity: a two-stage case-control study using a multilocus genotypingFausta Di Cianni, Daniele Campa, Federica Tallaro, et al.
Carcinogenesis|November 18, 2009
An insertion/deletion polymorphism at miRNA-122-binding site in the interleukin-1alpha 3' untranslated region confers risk for hepatocellular carcinomaYuzhen Gao, Yan He, Jun Ding, et al.
Carcinogenesis|December 15, 2011
The role of microRNA-binding site polymorphisms in DNA repair genes as risk factors for bladder cancer and breast cancer and their impact on radiotherapy outcomesMark T W Teo, Debora Landi, Claire F Taylor, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 5, 2016
A Comprehensive Meta-analysis of Case-Control Association Studies to Evaluate Polymorphisms Associated with the Risk of Differentiated Thyroid CarcinomaGisella Figlioli, Rossella Elisei, Cristina Romei, et al.
Plos One|January 28, 2014
MSLN gene silencing has an anti-malignant effect on cell lines overexpressing mesothelin deriving from malignant pleural mesotheliomaOmbretta Melaiu, Justin Stebbing, Ylenia Lombardo, et al.
Cancers|May 28, 2022
A Drug Screening Revealed Novel Potential Agents against Malignant Pleural MesotheliomaIrene Dell'Anno, Alessandra Melani, Sarah A Martin, et al.
Human Mutation|February 4, 2010
DeltaN133p53 expression levels in relation to haplotypes of the TP53 internal promoter regionIlaria Bellini, Letizia Pitto, Maria G Marini, et al.
BMC Cancer|March 18, 2016
Runs of homozygosity and inbreeding in thyroid cancerHauke Thomsen, Bowang Chen, Gisella Figlioli, et al.
Thyroid : Official Journal of the American Thyroid Association|April 2, 2020
Polymorphisms Within the <i>RET</i> Proto-Oncogene and Risk of Sporadic Medullary Thyroid CarcinomaFederica Gemignani, Cristina Romei, Raffaele Ciampi, et al.
International Journal of Hygiene and Environmental Health|October 8, 2008
Pooled analysis of NAT2 genotypes as risk factors for asbestos-related malignant mesotheliomaMarta Betti, Monica Neri, Daniela Ferrante, et al.
Pageof 22